Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148.6 USD | -0.46% | +1.20% | -5.21% |
05-06 | J&J: encouraging results in prostate cancer | CF |
05-06 | J&J: positive results in bladder cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.21% | 359B | |
+31.52% | 662B | |
+21.96% | 546B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B | |
-2.19% | 157B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Morgan Stanley Adjusts Johnson & Johnson's Price Target to $175 from $187, Keeps Equalweight Rating